Literature DB >> 10411869

Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine.

R C Gallo1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10411869      PMCID： PMC33620          DOI： 10.1073/pnas.96.15.8324

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  40 in total

1.  Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.

Authors:  C J Li; Y Ueda; B Shi; L Borodyansky; L Huang; Y Z Li; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report.

Authors:  A Gringeri; E Santagostino; M Cusini; M Muça-Perja; A Marinoni; P M Mannucci; A Burny; M Criscuolo; W Lu; J M Andrieru; J P Mbika; A Lachgar; L S Fall; V Chams; M Feldman; P Hermans; J F Zagury; B Bizzini; M Musicco; D Zagury
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-09

3.  Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.

Authors:  E F Petricoin; S Ito; B L Williams; S Audet; L F Stancato; A Gamero; K Clouse; P Grimley; A Weiss; J Beeler; D S Finbloom; E W Shores; R Abraham; A C Larner
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

4.  A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.

Authors:  P Wei; M E Garber; S M Fang; W H Fischer; K A Jones
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

5.  C-C chemokines, pivotal in protection against HIV type 1 infection.

Authors:  D Zagury; A Lachgar; V Chams; L S Fall; J Bernard; J F Zagury; B Bizzini; A Gringeri; E Santagostino; J Rappaport; M Feldman; S J O'Brien; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.

Authors:  K K Steger; M Dykhuizen; J L Mitchen; P W Hinds; B L Preuninger; M Wallace; J Thomson; D C Montefiori; Y Lu; C D Pauza
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.

Authors:  K Conant; A Garzino-Demo; A Nath; J C McArthur; W Halliday; C Power; R C Gallo; E O Major
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

8.  Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo.

Authors:  M Jenkins; M B Hanley; M B Moreno; E Wieder; J M McCune
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

9.  Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1.

Authors:  S Mitola; S Sozzani; W Luini; L Primo; A Borsatti; H Weich; F Bussolino
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

10.  Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

Authors:  D Zagury; A Lachgar; V Chams; L S Fall; J Bernard; J F Zagury; B Bizzini; A Gringeri; E Santagostino; J Rappaport; M Feldman; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205
View more
  32 in total

1.  Tat-neutralizing antibodies in vaccinated macaques.

Authors:  Ilia Tikhonov; Tracy J Ruckwardt; Glen S Hatfield; C David Pauza
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

Authors:  H Xiao; C Neuveut; H L Tiffany; M Benkirane; E A Rich; P M Murphy; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.

Authors:  Emmanuel Moreau; Johan Hoebeke; Daniel Zagury; Sylviane Muller; Claude Desgranges
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Identification of a novel sodium-coupled oligopeptide transporter (SOPT2) in mouse and human retinal pigment epithelial cells.

Authors:  Paresh P Chothe; Santoshanand V Thakkar; Jaya P Gnana-Prakasam; Sudha Ananth; David R Hinton; Ram Kannan; Sylvia B Smith; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

5.  Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.

Authors:  Laurent Mascarell; Catherine Fayolle; Cécile Bauche; Daniel Ladant; Claude Leclerc
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Authors:  Angélique Biancotto; Jean-Charles Grivel; Sarah J Iglehart; Christophe Vanpouille; Andrea Lisco; Scott F Sieg; Robert Debernardo; Kristen Garate; Benigno Rodriguez; Leonid B Margolis; Michael M Lederman
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

8.  A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.

Authors:  S M Agwale; M T Shata; M S Reitz; V S Kalyanaraman; R C Gallo; M Popovic; D M Hone
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-02       Impact factor: 11.205

9.  Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease.

Authors:  Bita Sahaf; Kondala Atkuri; Kartoosh Heydari; Meena Malipatlolla; Jay Rappaport; Emmanuel Regulier; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

10.  Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.

Authors:  Yida Yang; Ilia Tikhonov; Tracy J Ruckwardt; Mahmoud Djavani; Juan Carlos Zapata; C David Pauza; Maria S Salvato
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.